Low-risk patients | High-risk patients | P value | |
---|---|---|---|
N | 103 | 69 | |
Age (y) | 54.3 ± 9.53 | 59.8 ± 11.0 | P < 0.001b |
Histologic subtype | No lesion 2 | G1 18 | |
APAM 2 | G2 4 | ||
AEH 5 | G3 23 | ||
G1 71 | CL 4 | ||
G2 23 | S 12 | ||
CS 6 | |||
Others 2 | |||
T factor (TNM classification) | T1a without myometrial invasion 23 | T1a without myometrial invasion 3 | |
T1a 80 | T1a 22 | ||
T1b 22 | |||
T2 3 | |||
T3a 12 | |||
T3b 7 | |||
Lymph node metastasis | 0 | 13 | P < 0.001a |
CA125 (U/ml) | 37.7 ± 116.5 | 139.2 ± 414.5 | P < 0.001b |
CEA (ng/ml) | 4.35 ± 26.4 | 5.16 ± 15.0 | 0.02b |
CA19–9 (U/ml) | 55.1 ± 230.3 | 104.2 ± 255.3 | 0.74b |